Efficacy of ultrasound-guided sacral erector spinae plane block in laparoscopic hysterectomy

Analgesic effect of ultrasound-guided erector spinae plane block in patients undergoing laparoscopic hysterectomy: a clinical trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400094674

Enrollment

Unknown

Registered

2024-12-26

Start date

2025-01-01

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacral erector spinae block

Interventions

sacral erector spinae plane block group:Bilateral ultrasound-guided sacral erector spinae plane block with 20 ml of ropivacaine 0.375%

Sham block group:Bilateral subcutaneous local infiltration with 1 ml of ropivacaine 0.375% at the site of sacral erector spinae muscle block

Eligibility

Sex/Gender

Female

Age

35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 35-65 years, body mass index 18-27 kg/m^2, ASA classification I-II, can fully understand the research content.

Exclusion criteria

Exclusion criteria: Abnormal heart, liver and kidney function, local anesthetic allergy, contraindication of sacral erector spinae plane block, chronic pain or receiving chronic pain treatment.

Design outcomes

Primary

Measure	Time frame
sufentanil dosage;	—

Secondary

Measure	Time frame
remifentanil consumption during surgery;timing of first postoperative patient-controlled analgesia;postoperative pain numerical scale score;mean arterial pressure;heart rate;lower limb muscle strength;postoperative nausea and vomiting;timing of first flatus;timing of first ambulation;duration of urinary catheter retention;	—

Countries

China

Contacts

Public ContactWu Jin

Affiliated Hospital of Jiangsu University

wujin914@hotmail.com+86 159 0528 1553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026